Key result
Fenofibrate pretreatment reduces infarct size and improves cardiac function in rats with ischemia-reperfusion injury.
Why the study?
The mechanisms in energy metabolism underlying time-dependent coronary reperfusion after acute myocardial infarction remain largely unknown.
Early reperfusion and PPARα activation with fenofibrate protect against myocardial ischemia-reperfusion injury by maintaining cardiac metabolic homeostasis in a rat model.
Fenofibrate pretreatment merits testing in larger models; leaves open translation to clinical ischemia-reperfusion injury.
Timely percutaneous coronary intervention is the most effective initial therapy for the acute myocardial infarction (MI). However, the mechanism in energy metabolism underlying time-dependent coronary reperfusion remains largely unknown. Here, we generated an integrative map of cardiac cells using bulk and single-nucleus RNA-seq combined with metabolomics profiling of hearts with reperfusion at distinct time points post MI in rat. We found early time reperfusion (ETR), but not late time reperfusion (LTR) reduced myocardial injury by maintaining cardiac energy homeostasis. PPARα was identified as a key regulator for maintaining fatty acid metabolism after MI/R injury. Importantly, pretreatment with FDA-approved PPARα agonist, fenofibrate, improved the transcriptional signatures, and ameliorated the function of the MI/R injured hearts, particularly in the ETR. Together, our data not only deciphered the protective effect of ETR by maintaining cardiac energy homeostasis, but also provided insights into the translational potential of PPARα activation in alleviating MI/R injury.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2023) studied Myocardial ischemia-reperfusion injury. Fenofibrate vs. PBS was evaluated on Left ventricular ejection fraction and fractional shortening. Pretreatment with the PPARα agonist fenofibrate improved transcriptional signatures, reduced infarct size, and ameliorated cardiac function in rats with myocardial ischemia-reperfusion injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: